Literature DB >> 18998748

Management of acute kidney injury in children: a guide for pediatricians.

Sharon P Andreoli1.   

Abstract

Acute kidney injury (AKI; previously called acute renal failure) is characterized by a usually reversible increase in the blood concentration of creatinine and nitrogenous waste products and by the inability of the kidney to appropriately regulate fluid and electrolyte homeostasis. The incidence of AKI in children appears to be increasing and the etiology of AKI over the past decades has shifted from primary renal disease to multifactorial causes, particularly in hospitalized children. Renal failure can be divided into prerenal failure, intrinsic renal disease including vascular insults, and obstructive uropathies. The history, physical examination, and laboratory studies including a urinalysis and radiographic studies can establish the likely cause(s) of AKI. Once intrinsic renal failure has become established, management of the metabolic complications of AKI requires meticulous attention to fluid balance, electrolyte status, acid-base balance, and nutrition. Many children with AKI will need renal replacement therapy to remove endogenous and exogenous toxins and to maintain fluid, electrolyte, and acid-base balance until renal function improves. Renal replacement therapy may be provided by peritoneal dialysis (PD), intermittent hemodialysis (HD), or hemofiltration with or without a dialysis circuit. Many factors--including the age and size of the child, the cause of renal failure, the degree of metabolic derangements, blood pressure, and nutritional needs--are considered in deciding when to initiate renal replacement therapy and which modality of therapy to use. The prognosis of AKI is highly dependent on the underlying etiology of the AKI. Children who have AKI as a component of multisystem failure have a much higher mortality rate than children with intrinsic renal disease. Recovery from intrinsic renal disease is also highly dependent on the underlying etiology of the AKI. Children who have experienced AKI from any cause are at risk for late development of renal failure long after the initial insult. Such children need life-long monitoring of their renal function, blood pressure, and urinalysis.

Entities:  

Mesh:

Year:  2008        PMID: 18998748     DOI: 10.2165/0148581-200810060-00005

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  81 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

Review 2.  Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

Authors:  Jan O Friedrich; Neill Adhikari; Margaret S Herridge; Joseph Beyene
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

3.  Are children with a history of acute kidney injury at risk of later kidney disease?

Authors:  Sharon P Andreoli
Journal:  Nat Clin Pract Nephrol       Date:  2006-08

4.  Glucose and insulin versus cation-exchange resin for the treatment of hyperkalemia in very low birth weight infants.

Authors:  T A Malone
Journal:  J Pediatr       Date:  1991-01       Impact factor: 4.406

Review 5.  Prerenal failure: a deleterious shift from renal compensation to decompensation.

Authors:  K F Badr; I Ichikawa
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

6.  Multiple organ involvement in perinatal asphyxia.

Authors:  A Martín-Ancel; A García-Alix; F Gayá; F Cabañas; M Burgueros; J Quero
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

7.  A review of acute renal failure in children: incidence, etiology and outcome.

Authors:  N E Moghal; J T Brocklebank; S R Meadow
Journal:  Clin Nephrol       Date:  1998-02       Impact factor: 0.975

8.  Use of urinary indexes in renal failure in the newborn.

Authors:  E N Ellis; W C Arnold
Journal:  Am J Dis Child       Date:  1982-07

9.  Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial.

Authors:  Howard Trachtman; Avital Cnaan; Erica Christen; Kathleen Gibbs; Sanyi Zhao; David W K Acheson; Robert Weiss; Frederick J Kaskel; Adrian Spitzer; Gladys H Hirschman
Journal:  JAMA       Date:  2003-09-10       Impact factor: 56.272

10.  In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure.

Authors:  Daniela Benini; Vassilios Fanos; Laura Cuzzolin; Luciano Tatò
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

View more
  5 in total

Review 1.  Renal angina: an emerging paradigm to identify children at risk for acute kidney injury.

Authors:  Rajit K Basu; Lakhmir S Chawla; Derek S Wheeler; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2011-10-20       Impact factor: 3.714

2.  Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children.

Authors:  Brady S Moffett; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-06       Impact factor: 8.237

3.  Pediatric acute kidney injury assessed by pRIFLE as a prognostic factor in the intensive care unit.

Authors:  Nilzete Bresolin; Aline Patrícia Bianchini; Clarissa Alberton Haas
Journal:  Pediatr Nephrol       Date:  2012-11-24       Impact factor: 3.714

Review 4.  Management of hemolytic-uremic syndrome in children.

Authors:  Silviu Grisaru
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-06-12

5.  Combination of plasma exchange and haemofiltration for treating thrombotic microangiopathy in children.

Authors:  Jun Huang; Guangming Chen; Liqiang Ma; Ting Tan
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.